Erratum to "Prenatal cocaine use and maternal depression: Effects on infant neurobehavior"* [Neurotoxicol. Teratol. 29 (2007) 331-340] (DOI:10.1016/j.ntt.2006.12.001);Prenatal cocaine use and maternal depression: Effects on infant neurobehavior

Neurotoxicology and Teratology

Volumn 29, Issue 3, 2007, Pages 331-340

  Salisbury, Amy L ^a,b   Lester, Barry M ^a,b   Seifer, Ronald ^a,c   LaGasse, Linda ^a,b   Bauer, Charles R ^d   Shankaran, Seetha ^e   Bada, Henrietta ^f   Wright, Linda ^g   Liu, Jing ^a,b   Poole, Ken ^h  

^a BROWN UNIVERSITY   (United States)

^b WOMEN AND INFANTS HOSPITAL   (United States)

^c E P BRADLEY HOSPITAL   (United States)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

^g NATIONAL INSTITUTES OF HEALTH   (United States)

^h RTI INTERNATIONAL   (United States)

Author keywords

Cocaine; Depression; Infant; Neurobehavior; Postpartum

Indexed keywords

ALCOHOL; CANNABIS; COCAINE; NICOTINE;

ADULT; ALCOHOLISM; ARTICLE; CHILD DEVELOPMENT; COGNITION; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; PRENATAL EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PUERPERAL DEPRESSION;

EID: 34248633748     PISSN: 08920362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ntt.2008.08.003     Document Type: Erratum

References (72)

1. Results from the 2002 National Survey on Drug Use and Health: National Findings in (DHHS Publication No. SMA 03-3836, NHSDA Series H-22) (2003), Office of Applied Studies, Substance Abuse and Mental Health Services Administration, Rockville, MD
2. Akbari H.M., Kramer H.K., Whitaker-Azmitia P.M., Spear L.P., and Azmitia E.C. Prenatal cocaine exposure disrupts the development of the serotonergic system. Brain Res. 572 (1992) 57-63
3. Armstrong K.L., O'Donnell H., McCallum R., and Dadds M. Childhood sleep problems: association with prenatal factors and maternal distress/depression. J. Paediatr. Child Health 34 (1998) 263-266
4. Atkinson A.K., and Rickel A.U. Postpartum depression in primiparous parents. J. Abnorm. Psychol. 93 (1984) 115-119
5. Batson H.W., Brown Jr. L.S., Zaballero A.R., Chu A., and Alterman A.I. Conflicting measurements of depression in a substance abuse population. J. Subst. Abuse 5 (1993) 93-100
6. Bauer C.R., Shankaran S., Bada H.S., Lester B., Wright L.L., Krause-Steinrauf H., Smeriglio V.L., Finnegan L.P., Maza P.L., and Verter J. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am. J. Obstet. Gynecol. 186 (2002) 487-495
7. Bendersky M., and Lewis M. Arousal modulation in cocaine-exposed infants. Dev. Psychobiol. 34 (1998) 555-564
8. Brazelton T.B. Neonatal Behavioral Assessment Scale (1984), Lippincott, Philadelphia, PA
9. Brown J., Bakeman A., Coles C.D., Sexson W.A., and Demi A.S. Maternal drug use during pregnancy: are preterms and full-terms affected differently?. Dev. Psychol. 34 (1998) 540-554
10. Campbell S.B., and Cohn J.F. Prevalence and correlates of postpartum depression in first-time mothers. J. Abnorm. Psychol. 100 (1991) 594-599
11. Chasnoff I.J., Burns W.J., Schnoll S.H., and Burns K.A. Cocaine use in pregnancy. N. Engl. J. Med. 313 (1985) 666-669
12. Chasnoff I.J., Burns K.A., and Burns W.J. Cocaine use in pregnancy: perinatal morbidity and mortality. Neurotoxicol. Teratol. 9 (1987) 291-293
13. Chaudron L.H., Kitzman H.J., Peifer K.L., Morrow S., Perez L.M., and Newman M.C. Prevalence of maternal depressive symptoms in low-income Hispanic women. J. Clin. Psychiatry 66 (2005) 418-423
14. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Second ed. (1988), Lawrence Erlbaum Associates, Hillsdale, New Jersey 567
15. Da Costa D., Larouche J., Dritsa M., and Brender W. Psychosocial correlates of prepartum and postpartum depressed mood. J. Affect. Disord. 59 (2000) 31-40
16. Desai H.D., and Jann M.W. Major depression in women: a review of the literature. J. Am. Pharm. Assoc. 40 (2000) 525-537
17. DiPietro J.A., Suess P.E., Wheeler J.S., Smouse P.H., and Newlin D.B. Reactivity and regulation in cocaine-exposed neonates. Infant Behav. Dev. 18 (1995) 407-414
18. Dow-Edwards D.L. Cocaine effects on fetal development: a comparison of clinical and animal research findings. Neurotoxicol. Teratol. 13 (1991) 347-352
19. Dow-Edwards D.L. Modification of acoustic startle reactivity by cocaine administration during the postnatal period: comparison with a specific serotonin reuptake inhibitor. Neurotoxicol. Teratol. 18 (1996) 289-296
20. Dow-Edwards D.L. Preweaning cocaine administration alters the adult response to quipazine: comparison with fluoxetine. Neurotoxicol. Teratol. 20 (1998) 133-142
21. ElSohly M.A., Stanford D.F., Murphy T.P., Lester B.M., Wright L.L., Smeriglio V.L., Verter J., Bauer C.R., Shankaran S., Bada H.S., and Walls H.C. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium. J. Anal. Toxicol. 23 (1999) 436-445
22. Ferguson A., Coyle M.G., LaGasse L., Liu E., and Lester B. Neurobehavioral effects of treatment for opiate withdrawal. Pediatr. Res. 49 (2001) 18A
23. Field T. Maternal depression effects on infants and early interventions. Prev. Med. 27 (1998) 200-203
24. Finnegan L.P., Kron R.E., Connaughton J.F., and Emich J.P. Assessment and treatment of abstinence in the infant of the drug-dependent mother. Int. J. Clin. Pharmacol. Biopharm. 12 (1975) 19-32
25. Fulroth R., Phillips B., and Durand D.J. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am. J. Dis. Child 143 (1989) 905-910
26. Gingras J.L., Feibel J., Dalley B., and Muelenaer A. Maternal polydrug use including cocaine and postnatal infant sleep architecture: preliminary observations and implications for respiratory control and behavior. Early Hum. Dev. 43 (1995) 197-204
27. Gotlib I.H., Whiffen V.E., Mount J.H., Milne K., and Cordy N.I. Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J. Consult. Clin. Psychol. 57 (1989) 269-274
28. Hasin D.S., Hatzenbueler M., Smith S., and Grant B.F. Co-occurring DSM-IV drug abuse in DSM-IV drug dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Drug Alcohol Depend. 80 (2005) 117-123
29. Hiscock H., and Wake M. Infant sleep problems and postnatal depression: a community-based study. Pediatrics 107 (2001) 1317-1322
30. Jacobson J., and Jacobson S. Methodological issues in human behavioral teratology. In: Rovee-Collier C., and Lipsitt L.P. (Eds). Advances in Infancy Research (1990), Plenum Publishing, New York, NY 111-148
31. Johnson R.E., Jones H.E., Jasinski D.R., Svikis D.S., Haug N.A., Jansson L.M., Kissin W.B., Alpan G., Lantz M.E., Cone E.J., Wilkins D.G., Golden A.S., Huggins G.R., and Lester B.M. Buprenorphine treatment of pregnant opioid-dependent women: maternal and neonatal outcomes. Drug Alcohol Depend. 63 (2001) 97-103
32. Jones N.A., Field T., Fox N., Davalos M., Lundy B., and GHart S. Newborns of mothers with depressive symptoms are physiologically less developed. Infant Behav. Dev. 21 (1998) 537-541
33. Josefsson A., Berg G., Nordin C., and Sydsjo G. Prevalence of depressive symptoms in late pregnancy and postpartum. Acta Obstet. Gynecol. Scand. 80 (2001) 251-255
34. Karmel B.Z., and Gardner J.M. Prenatal cocaine exposure effects on arousal-modulated attention during the neonatal period. Dev. Psychobiol. 29 (1996) 463-480
35. Kosten T.R., Rounsaville B.J., and Kleber H.D. Concurrent validity of the addiction severity index. J. Nerv. Ment. Dis. 171 (1983) 606-610
36. LaGasse L.L., Seifer R., and Lester B.M. Interpreting research on prenatal substance exposure in the context of multiple confounding factors. Clin. Perinatol. 26 (1999) 39-54 (vi.)
37. Law K.L., Stroud L.R., LaGasse L.L., Niaura R., Liu J., and Lester B.M. Smoking during pregnancy and newborn neurobehavior. Pediatrics 111 (2003) 1318-1323
38. Leon D.A. Failed or misleading adjustment for confounding. Lancet 342 (1993) 479-481
39. Lester B.M. The Maternal Lifestyles Study. Ann. N.Y. Acad. Sci. 846 (1998) 296-305
40. Lester B., and Tronick E. The effects of prenatal cocaine exposure and child outcome: lessons from the past. Inf. Ment. Health J. 15 (1994) 107-120
41. Lester B.M., and Tronick E.Z. History and description of the Neonatal Intensive Care Unit Network Neurobehavioral Scale. Pediatrics 113 (2004) 634-640
42. Lester B., T. EZ, and M.L. Neurodevelopmental consortium, the NICHD Neonatal research network. A neurodevelopmental follow-up battery for substance exposed infants. Pediatr. Res. 35 (1994) 23A
43. Lester B.M., ElSohly M., Wright L.L., Smeriglio V.L., Verter J., Bauer C.R., Shankaran S., Bada H.S., Walls H.H., Huestis M.A., Finnegan L.P., and Maza P.L. The Maternal Lifestyle Study: drug use by meconium toxicology and maternal self-report. Pediatrics 107 (2001) 309-317
44. Lester B.M., Tronick E.Z., LaGasse L., Seifer R., Bauer C.R., Shankaran S., Bada H.S., Wright L.L., Smeriglio V.L., Lu J., Finnegan L.P., and Maza P.L. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 110 (2002) 1182-1192
45. Lester B.M., Lagasse L., Seifer R., Tronick E.Z., Bauer C.R., Shankaran S., Bada H.S., Wright L.L., Smeriglio V.L., Liu J., Finnegan L.P., and Maza P.L. The Maternal Lifestyle Study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month. J. Pediatr. 142 (2003) 279-285
46. Lester B.M., Tronick E.Z., LaGasse L., Seifer R., Bauer C.R., Shankaran S., Bada H.S., Wright L.L., Smeriglio V.L., and Lu J. Summary statistics of neonatal intensive care unit network neurobehavioral scale scores from the maternal lifestyle study: a quasinormative sample. Pediatrics 113 (2004) 668-775
47. Mayes L.C., Bornstein M.H., Chawarska K., Haynes C.M., and Granger A.H. Impaired regulation of arousal in three-month-old infants exposed prenatally to cocaine and other drugs. Dev. Psychopathol. 8 (1996) 29-42
48. Mayes L.C. Developing brain and in utero cocaine exposure: effects on neural ontogeny. Dev. Psychopathol. 11 (1999) 685-714
49. Mayes L.C. A behavioral teratogenic model of the impact of prenatal cocaine exposure on arousal regulatory systems. Neurotox. Teratol. 24 (2002) 385-395
50. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom G., Pettinati H., and Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse Treat. 9 (1992) 199-213
51. Morrow C.E., Bandstra E.S., Anthony J.C., Ofir A.Y., Xue L., and Reyes M.L. Influence of prenatal cocaine exposure on full-term infant neurobehavioral functioning. Neurotox. Teratol. 23 (2001) 533-544
52. Murray L. The impact of postnatal depression on infant development. J. Child Psychol. Psychiatry 33 (1992) 543-561
53. Murray L., Fiori-Cowley A., Hooper R., and Cooper P. The impact of postnatal depression and associated adversity on early mother-infant interactions and later infant outcome. Child Dev. 67 (1996) 2512-2526
54. Napiorkowski B., Lester B.M., Freier M.C., Brunner S., Dietz L., Nadra A., and Oh W. Effects of in utero substance exposure on infant neurobehavior. Pediatrics 98 (1996) 71-75
55. Neuspiel D.R., Hamel S.C., Hochberg E., Greene J., and Campbell D. Maternal cocaine use and infant behavior. Neurotox. Teratol. 13 (1991) 229-233
56. O'Hara M., Neunaber D.J., and Zekoski E.M. Prospective study of postpartum depression: prevalence, course, and predictive factors. J. Abnorm. Psychol. 93 (1984) 158-171
57. O'Hara M.W., Zekoski E.M., Philipps L.H., and Wright E.J. Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J. Abnorm. Psychol. 99 (1990) 3-15
58. O'Hara M.W., Schlechte J.A., Lewis D.A., and Wright E.J. Prospective study of postpartum blues. Biologic and psychosocial factors. Arch. Gen. Psychiatry 48 (1991) 801-806
59. Oro A.S., and Dixon S.D. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J. Pediatr. 111 (1987) 571-578
60. Pajulo M., Savonlahti E., Sourander A., Helenius H., and Piha J. Antenatal depression, substance dependency and social support. J. Affect. Disord. 65 (2001) 9-17
61. 2+ current inhibition produced by serotonin in rat dorsal raphe neurons. J. Neurosci. 11 (1991) 3594-3609
62. Regalado M.G., Schechtman V.L., Del Angel A.P., and Bean X.D. Sleep disorganization in cocaine-exposed neonates. Infant Behav. Dev. 18 (1995) 319-327
63. Richardson G., and Day N. Studies of prenatal cocaine exposure: assessing the influence of extraneous variables. J. Drug Issues 29 (1999) 225-236
64. Rounsaville B.J., Kosten T.R., Weissman M.M., and Kleber H.D. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch. Gen. Psychiatry 43 (1986) 739-745
65. Scafidi F.A., Field T.M., Wheeden A., Schanberg S., Kuhn C., Symanski R., Zimmerman E., and Bandstra E.S. Cocaine-exposed preterm neonates show behavioral and hormonal differences. Pediatrics 97 (1996) 851-855
66. Singer L., Arendt R., and Minnes S. Neurodevelopmental effects of cocaine. Clin. Perinatol. 20 (1993) 245-262
67. Singer L.T., Salvator A., Arendt R., Minnes S., Farkas K., and Kliegman R. Effects of cocaine/polydrug exposure and maternal psychological distress on infant birth outcomes. Neurotoxicol. Teratol. 24 (2002) 127-135
68. Whiffen V.E., and Gotlib I.H. Infants of postpartum depressed mothers: temperament and cognitive status. J. Abnorm. Psychol. 98 (1989) 274-279
69. Wisner K.L., Peindl K.S., and Hanusa B.H. Psychiatric episodes in women with young children. J. Affect. Disord. 34 (1995) 1-11
70. Woods N.S., Eyler F.D., Behnke M., and Conlon M. Cocaine use during pregnancy: maternal depressive symptoms and infant neurobehavior over the first month. Infant Behav. Dev. 16 (1993) 83-98
71. Zuckerman B., Frank D.A., Hingson R., Amaro H., Levenson S.M., Kayne H., Parker S., Vinci R., Aboagye K., Fried L.E., et al. Effects of maternal marijuana and cocaine use on fetal growth. N. Engl. J. Med. 320 (1989) 762-768
72. Zuckerman B., Bauchner H., Parker S., and Cabral H. Maternal depressive symptoms during pregnancy, and newborn irritability. J. Dev. Behav. Pediatr. 11 (1990) 190-194